Market Cap | 2.11B | P/E | - | EPS this Y | -17.90% | Ern Qtrly Grth | - |
Income | 212.4M | Forward P/E | 15.91 | EPS next Y | 48.20% | 50D Avg Chg | 5.00% |
Sales | 3.04B | PEG | 1.62 | EPS past 5Y | -41.77% | 200D Avg Chg | 26.00% |
Dividend | N/A | Price/Book | 18.12 | EPS next 5Y | 10.00% | 52W High Chg | -12.00% |
Recommedations | 2.40 | Quick Ratio | 1.39 | Shares Outstanding | 122.35M | 52W Low Chg | 109.00% |
Insider Own | 10.68% | ROA | 4.75% | Shares Float | 99.78M | Beta | 2.28 |
Inst Own | 117.03% | ROE | 95.51% | Shares Shorted/Prior | 27.11M/29.65M | Price | 17.34 |
Gross Margin | 49.43% | Profit Margin | 7.12% | Avg. Volume | 2,598,880 | Target Price | 20.60 |
Oper. Margin | 3.11% | Earnings Date | Aug 2 | Volume | 2,852,649 | Change | 2.36% |
Cinemark Holdings, Inc., together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc. was founded in 1984 and is headquartered in Plano, Texas.
B. Riley Securities | Neutral | May 3, 24 |
Benchmark | Buy | May 3, 24 |
Wedbush | Outperform | Apr 25, 24 |
Barrington Research | Outperform | Apr 22, 24 |
Wedbush | Outperform | Apr 18, 24 |
Roth MKM | Neutral | Apr 10, 24 |
Benchmark | Buy | Apr 10, 24 |
JP Morgan | Neutral | Apr 8, 24 |
Wells Fargo | Overweight | Apr 5, 24 |